Colorectal Cancer Drugs Market 2020-2030 Pre-Post COVID-19 Scenario | Leading Players : US Food and Administration Agency, European Medicines Agency, American Society of Clinical Oncology

The Business Research Company offers "Colorectal Cancer Drugs Global Market Report 2020-30: Covid 19 Impact And Recovery" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global colorectal cancer drugs market is expected to decline from $6.9 billion in 2019 to $5.9 billion in 2020 at a compound annual growth rate (CAGR) of -15.3%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. Hospitals across the world have postponed the chemo treatments for cancer patients due to covid positive cases in the hospitals. The sessions are delayed or postponed to prevent patients and staff from unnecessary exposure. The cancer treatment can lower the patient`s ability to fight infection. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 3.1% from 2021 and reach $7.6 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2590

The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting large intestine and the rectum. They are also named, colon tumor or rectal cancer depending upon where they begin.

Increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body’s immune system to fight cancer rather than chemical drugs which reduces the body’s immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective.

Colorectal Cancer Drugs Market Segmentation:
By Type
1.Vascular Endothelial Growth Factor (VEGF) Inhibitors
2.Epidermal Growth Factor Receptor (EGFR) Inhibitors
3.Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
4.BRAF or MEK Inhibitors
5.Tyrosine Kinase (TKI) Inhibitors
6.Immunomodulators

By Distribution Channels
1.Hospitals Pharmacies
2.Retail Pharmacies and Others

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Colorectal Cancer Drugs Market Characteristics
3. Colorectal Cancer Drugs Market Size And Growth
4. Colorectal Cancer Drugs Market Segmentation
5. Colorectal Cancer Drugs Market Regional And Country Analysis
....
25. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market
27. Colorectal Cancer Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the colorectal cancer drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smp

Some of the key players involved in the colorectal cancer drugs market are Merck & Co. Inc, Roche, Sanofi, Amgen, PFIZER, INC., Abbott Laboratories, Taiho Pharma, Novartis

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.